One-carbon metabolite levels in mid-pregnancy and risks of conotruncal heart defects

Birth Defects Research Part A - Clinical and Molecular Teratology

Volumn 100, Issue 2, 2014, Pages 107-115

  Shaw, Gary M ^a   Yang, Wei ^a   Carmichael, Suzan L ^a   Vollset, Stein Emil ^b   Hobbs, Charlotte A ^c   Lammer, Edward J ^d   Ueland, Per M ^e  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

^c UNIVERSITY OF ARKANSAS AT LITTLE ROCK   (United States)

^d CHILDREN S HOSPITAL OAKLAND RESEARCH INSTITUTE   (United States)

^e UNIVERSITY OF BERGEN   (Norway)

Author keywords

B vitamins; Folic acid; Heart defects; Nutrition; Pregnancy

Indexed keywords

B VITAMINS; FOLIC ACID; HEART DEFECTS; NUTRITION; PREGNANCY;

ADULT; BIOLOGICAL SPECIMEN BANKS; CALIFORNIA; CASE-CONTROL STUDIES; FEMALE; HEART DEFECTS, CONGENITAL; HUMANS; INFANT, NEWBORN; METABOLOME; PREGNANCY; PREGNANCY TRIMESTER, SECOND; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 84894271622     PISSN: 15420752     EISSN: 15420760     Source Type: Journal    
DOI: 10.1002/bdra.23224     Document Type: Article

References (25)

1. Bailey LB, Berry RJ. 2005. Folic acid supplementation and the occurrence of congenital heart defects, orofacial clefts, multiple births, and miscarriage. Am J Clin Nutr 81(Suppl)1213s-1217s.
2. Botto LD, Correa A. 2003. Decreasing the burden of congenital heart anomalies: an epidemiologic evaluation of risk factors and survival. Prog Ped Cardiol 18:111-121.
3. Botto LD, Khoury MJ, Mulinare J, Erickson JD. 1996. Periconceptional multivitamin use and the occurrence of conotruncal heart defects: results from a population-based, case-control study. Pediatrics 98:911-917.
4. Botto LD, Mulinare J, Erickson JD. 2000. Occurrence of congenital heart defects in relation to maternal multivitamin use. Am J Epidemiol 151:878-884.
5. Botto LD, Olney RS, Erickson JD. 2004. Vitamin supplements and the risk for congenital anomalies other than neural tube defects. Am J Med Genet Part C (Semin Med Genet) 125C:12-21.
6. Chan J, Deng L, Mikael LG, et al. 2010. Low dietary choline and low dietary riboflavin during pregnancy influence reproductive outcomes and heart development in mice. Am J Clin Nutr 91:1035-1043.
7. Croen LA, Shaw GM, Jensvold NJ, Harris JA. 1991. Birth defects monitoring in California: a resource for epidemiologic research. Paediatr Perinat Epidemiol 5:423-427.
8. Ferencz C, Rubin JD, McCarter RJ, et al. 1985. Congenital heart disease: prevalence at livebirth. The Baltimore-Washington Infant Study. Am J Epidemiol 121:31-36.
9. Hobbs CA, Cleves MA, Melnyk S, et al. 2005a. Congenital heart defects and abnormal maternal biomarkers of methionine and homocysteine metabolism. Am J Clin Nutr 81:147-153.
10. Hobbs CA, Cleves MA, Zhao W, et al. 2005b. Congenital heart defects and maternal biomarkers of oxidative stress. Am J Clin Nutr 82:598-604.
11. Hobbs CA, Malik S, Zhao W, et al. 2006. Maternal homocysteine and congenital heart defects. J Am Coll Cardiol 47:683-685.
12. Holm PI, Ueland PM, Kvalheim G, Lien EA. 2003. Determination of choline, betaine, and dimethylglycine in plasma by a high-throughput method based on normal-phase chromatography-tandem mass spectrometry. Clin Chem 49:286-294.
13. Hustad S, Eussen S, Midttun O, et al. 2012. Kinetic modeling of storage effects on biomarkers related to B vitamin status and one-carbon metabolism. Clin Chem 58:402-410.
14. Kapusta L, Haagmans ML, Steegers EA, et al. 1999. Congenital heart defects and maternal derangement of homocysteine metabolism. J Pediatr 135:773-774.
15. Midttun O, Kvalheim G, Ueland PM. 2013. High-throughput, low-volume, multianalyte quantification of plasma metabolites related to one-carbon metabolism using hplc-ms/ms. Anal Bioanal Chem 405:2009-2017.
16. Shaw GM, Carmichael SL, Yang W, Lammer EJ. 2010. Periconceptional nutrient intakes and risks of conotruncal heart defects. Birth Defects Res A Clin Mol Teratol 88:144-151.
17. Shaw GM, Finnell RH, Blom HJ, et al. 2009a. Choline and risk of neural tube defects in a folate-fortified population. Epidemiology 20:714-719.
18. Shaw GM, O'Malley CD, Wasserman CR, et al. 1995. Maternal periconceptional use of multivitamins and reduced risk for conotruncal heart defects and limb deficiencies among offspring. Am J Med Genet 59:536-545.
19. Shaw GM, Vollset SE, Carmichael SL, et al. 2009b. Nested case-control study of one-carbon metabolites in mid-pregnancy and risks of cleft lip with and without cleft palate. Pediatr Res 66:501-506.
20. Sutton M, Mills JL, Molloy AM, et al. 2011. Maternal folate, vitamin B12 and homocysteine levels in pregnancies affected by congenital malformations other than neural tube defects. Birth Defects Res A Clin Mol Teratol 91:610-615.
21. Ueland PM, Midttun O, Windelberg A, et al. 2007. Review: quantitative profiling of folate and one-carbon metabolism in large-scale epidemiological studies by mass spectrometry. Clin Chem Lab Med 45:1737-1745.
22. Van Beynum IM, Kouwenberg M, Kapusta L, et al. 2006. MTRR 66A>G polymorphism in relation to congenital heart defects. Clin Chem Lab 44:1317-1323.
23. Van den Veyver I. 2002. Genetic effects of methylation diets. Annu Rev Nutr 22:255-282.
24. Verkleij-Hagoort AC, van Driel LMJW, Lindemans J, et al. 2008. Genetic and lifestyle factors related to the periconception vitamin B12 status and congenital heart defects: a Dutch case-control study. Mol Genet Metabol 94:112-119.
25. Wenstrom KD, Johanning GL, Johnston KE, DuBard M. 2001. Association of the C677T methylenetetrahydrofolate reductase mutation and elevated homocysteine levels with congenital cardiac malformations. Am J Obstet Gnecol 184:806-817.